Simcere Pharmaceutical Group Limited
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:67,632.68 tCO2e/year
Scope 1 Emissions:4,996.50 tCO2e/year
Scope 2 Emissions:62,636.18 tCO2e/year
Total Energy Consumption:80,061,679.53 kWh/year
Water Consumption:1,178,901.14 tonnes/year
Waste Generated:4,048.87 tonnes/year
Carbon Intensity:0.10 tCO2e per 10,000 RMB revenue
ESG Focus Areas
- ESG governance
- Corporate governance
- Innovation benefiting the public
- Quality assurance
- Talent construction
- Low-carbon operation
- Caring society
Environmental Achievements
- Greenhouse gas emissions per RMB 10,000 of revenue decreased by 31.31% compared with 2020.
- Water consumption per RMB 10,000 revenue lowered by 17.87% in 2023 compared with 2020.
- Purchased electricity consumption per RMB 10,000 revenue lowered by 23.46% in 2023 compared with 2020.
- 100% of factories were certified with ISO 14001 Environmental Management System.
Social Achievements
- RMB 67.13 million charitable donation.
- 100% of employees received training, with an average of 39.7 training hours per employee.
- Female employees accounted for 52.2% of the total workforce and 44.3% of middle-level and senior management positions.
- Zero incidents of forced labor or child labor.
- Successfully accomplished the ESG management targets set in the 2022 ESG Report.
Governance Achievements
- Established a three-tier ESG governance structure comprising the Board, the Strategy Committee, and the ESG Group.
- Improved the compliance and anti-corruption management system.
- Implemented a supplier risk management system.
- Successfully accomplished the ESG management targets set in the 2022 ESG Report.
Climate Goals & Targets
Short-term Goals:
- Lower greenhouse gas emissions per RMB 10,000 of revenue by no less than 10% by 2025.
- Lower water consumption per RMB 10,000 revenue by no less than 10% by 2025.
- Lower purchased electricity consumption per RMB 10,000 of revenue by no less than 10% by 2025.
- Lower solid waste discharge per RMB 10,000 revenue by 15% by 2025.
Environmental Challenges
- Tightened climate change policies increasing the cost of compliant operation.
- Changes in market demand for more environmentally friendly and low-carbon products.
- Stakeholders' concerns demanding higher response requirements in terms of climate issues.
- Extreme weather events causing damage to operating assets and equipment.
- Long high-temperature periods increasing energy consumption.
- Water shortage increasing operating costs.
- Trade secret and intellectual property protection risk.
- Post-marketing medical research risk.
- Data security and compliance risk.
- Business ethics risk.
Mitigation Strategies
- Developed sound work plans, set targets for carbon emissions, improved energy efficiency, and improved chemical technologies.
- Promoted the use of low-carbon fuels and renewable energy, promoted resource conservation awareness, and optimized transportation.
- Disclosed data on greenhouse gas emissions and low-carbon operations.
- Established emergency response teams, consulted professional third parties, and improved supply chain resilience.
- Strengthened plant inspections and installed reliable facilities.
- Increased water use efficiency and carried out water-saving activities.
- Released the Intellectual Property Management System, implemented confidentiality measures, and issued management standards for donated drugs.
- Issued the Human Genetic Resources Management System and organized special training.
- Released the Simcere Compliance Guidelines for Anti-Monopoly and organized legal knowledge training.
- Convened supplier meetings and organized compliance training.
Supply Chain Management
Supplier Audits: 151 suppliers audited for material quality
Responsible Procurement
- Supplier Management System
- Procurement, Tendering and Bidding System
- Second Supplier Development System for Production Materials
Climate-Related Risks & Opportunities
Physical Risks
- Extreme weather
- Water shortage
Transition Risks
- Policy risk
- Market risk
Opportunities
- Public health demand
- Support from green finance
- Efficiency in resource use
- Clean energy usage
Reporting Standards
Frameworks Used: Appendix 27 Environmental, Social, and Governance Reporting Guide of the Main Board Listing Rules of the Hong Kong Exchanges and Clearing Limited (HKEX)
Certifications: ISO 9001, ISO 14001, EU GMP
Awards & Recognition
- Top 100 Enterprises in China's Pharmaceutical Industry
- Jiangsu Enterprise Technology Innovation Award
- National Intellectual Property Demonstration Enterprise
- Top Industrial Enterprise
- Ranked 3rd among the Top 20 Hainan Private Enterprises in R&D Investment
- Ranked 22nd among the Top 50 Hainan Private Enterprises
- Ranked 16th among the Top 40 Hainan Manufacturing Enterprises
- Leading and High-quality Pharmaceutical Development Enterprise
- Leading and High-quality Pharmaceutical Development Brand
- Excellent Case Award for Digital Transformation
- An Advanced Collective
- China Health Public Welfare Star